Moreover, gene expression analysis revealed that CLL cells derived from the lymph nodes of patients (the likely site of BCR stimulation of CLL cells by antigen in vivo) have increased expression of gene signatures related to mRNA translation compared to CLL cells in the blood. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.